WallStreetZenWallStreetZen

NYSE: LH
Labcorp Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LH

Based on 9 analysts offering 12 month price targets for Labcorp Holdings Inc

Min Forecast
$275.00-1.14%
Avg Forecast
$294.89+6.01%
Max Forecast
$310.00+11.44%

Should I buy or sell LH stock?

Based on 9 analysts offering ratings for Labcorp Holdings Inc.

Strong Buy
Strong Buy
5 analysts 55.56%
Buy
2 analysts 22.22%
Hold
2 analysts 22.22%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their LH stock forecasts and price targets.

LH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-25Find Out Why
lockedlocked$00.00+00.00%2025-07-25
lockedlocked$00.00+00.00%2025-07-25
lockedlocked$00.00+00.00%2025-07-25Find Out Why
lockedlocked$00.00+00.00%2025-07-25
Barclays
Top 7%
94
HoldMaintains$275.00-1.14%2025-06-25
Piper Sandler
Top 10%
91
HoldMaintains$280.00+0.65%2025-05-06
Redburn Atlantic
Top 46%
55
Strong BuyInitiates Coverage On$276.00-0.78%2025-04-02
Citigroup
Bottom 10%
10
Strong BuyUpgrades$300.00+7.84%2025-03-04

1 of 1

Forecast return on equity

Is LH forecast to generate an efficient return?

Company
22.11%
Industry
70.97%
Market
-49.12%
LH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LH forecast to generate an efficient return on assets?

Company
10.37%
Industry
21.46%
LH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LH earnings per share forecast

What is LH's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$16.30+78.52%
Avg 2 year Forecast
$17.89+95.92%
Avg 3 year Forecast
$19.41+112.63%
LH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

LH revenue forecast

What is LH's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$14.0B+3.86%
Avg 2 year Forecast
$14.7B+9.04%
Avg 3 year Forecast
$15.5B+14.99%
LH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LH earnings growth forecast

How is LH forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
28.63%
Industry
15.52%
Market
15.31%
LH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
LH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
LH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

LH revenue growth forecast

How is LH forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
4.71%
Industry
5.28%
Market
10.83%
LH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
LH$278.18$294.89+6.01%Strong Buy
NTRA$165.60$202.67+22.38%Strong Buy
DGX$180.23$188.00+4.31%Hold
MTD$1,321.45$1,292.50-2.19%Buy
WAT$302.19$366.89+21.41%Buy
View Top Diagnostic & Research Stocks

Labcorp Holdings Stock Forecast FAQ

Is Labcorp Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: LH) stock is to Strong Buy LH stock.

Out of 9 analysts, 5 (55.56%) are recommending LH as a Strong Buy, 2 (22.22%) are recommending LH as a Buy, 2 (22.22%) are recommending LH as a Hold, 0 (0%) are recommending LH as a Sell, and 0 (0%) are recommending LH as a Strong Sell.

If you're new to stock investing, here's how to buy Labcorp Holdings stock.

What is LH's earnings growth forecast for 2025-2027?

(NYSE: LH) Labcorp Holdings's forecast annual earnings growth rate of 28.63% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 15.52%, and it is also forecast to beat the US market's average forecast earnings growth rate of 15.31%.

Labcorp Holdings's earnings in 2025 is $763,400,000.On average, 8 Wall Street analysts forecast LH's earnings for 2025 to be $1,354,471,830, with the lowest LH earnings forecast at $1,347,051,000, and the highest LH earnings forecast at $1,362,840,000. On average, 9 Wall Street analysts forecast LH's earnings for 2026 to be $1,486,418,010, with the lowest LH earnings forecast at $1,437,630,000, and the highest LH earnings forecast at $1,648,704,000.

In 2027, LH is forecast to generate $1,613,253,540 in earnings, with the lowest earnings forecast at $1,570,590,000 and the highest earnings forecast at $1,662,000,000.

What is LH's revenue growth forecast for 2025-2027?

(NYSE: LH) Labcorp Holdings's forecast annual revenue growth rate of 4.71% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.

Labcorp Holdings's revenue in 2025 is $13,483,800,000.On average, 6 Wall Street analysts forecast LH's revenue for 2025 to be $1,163,759,573,700, with the lowest LH revenue forecast at $1,160,524,740,000, and the highest LH revenue forecast at $1,167,056,400,000. On average, 8 Wall Street analysts forecast LH's revenue for 2026 to be $1,221,772,930,200, with the lowest LH revenue forecast at $1,208,672,880,000, and the highest LH revenue forecast at $1,235,298,120,000.

In 2027, LH is forecast to generate $1,288,448,880,000 in revenue, with the lowest revenue forecast at $1,263,535,500,000 and the highest revenue forecast at $1,322,518,550,400.

What is LH's forecast return on assets (ROA) for 2025-2028?

(NYSE: LH) forecast ROA is 10.37%, which is lower than the forecast US Diagnostics & Research industry average of 21.46%.

What is LH's Price Target?

According to 9 Wall Street analysts that have issued a 1 year LH price target, the average LH price target is $294.89, with the highest LH stock price forecast at $310.00 and the lowest LH stock price forecast at $275.00.

On average, Wall Street analysts predict that Labcorp Holdings's share price could reach $294.89 by Jul 25, 2026. The average Labcorp Holdings stock price prediction forecasts a potential upside of 6.01% from the current LH share price of $278.18.

What is LH's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: LH) Labcorp Holdings's current Earnings Per Share (EPS) is $9.13. On average, analysts forecast that LH's EPS will be $16.30 for 2025, with the lowest EPS forecast at $16.21, and the highest EPS forecast at $16.40. On average, analysts forecast that LH's EPS will be $17.89 for 2026, with the lowest EPS forecast at $17.30, and the highest EPS forecast at $19.84. In 2027, LH's EPS is forecast to hit $19.41 (min: $18.90, max: $20.00).

What is LH's forecast return on equity (ROE) for 2025-2028?

(NYSE: LH) forecast ROE is 22.11%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.